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c-Rel is required for the development
of thymic Foxp3+ CD4 regulatory T cells
Iwao Isomura,1 Stephanie Palmer,2 Raelene J. Grumont,1 Karen Bunting,2
Gerard Hoyne,2 Nancy Wilkinson,2 Ashish Banerjee,1 Anna Proietto,1
Raffi Gugasyan,1 Wu Li,1 Alice McNally,3 Raymond J. Steptoe,3
Ranjeny Thomas,3 M. Frances Shannon,2 and Steve Gerondakis1
1The

Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia
John Curtin School of Medical Research, Australian National University, Canberra City ACT 2601, Australia
3Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Queensland 4102, Australia

During thymopoiesis, a unique program of gene expression promotes the development of
CD4 regulatory T (T reg) cells. Although Foxp3 maintains a pattern of gene expression
necessary for T reg cell function, other transcription factors are emerging as important
determinants of T reg cell development. We show that the NF-B transcription factor
c-Rel is highly expressed in thymic T reg cells and that in c-rel/ mice, thymic T reg cell
numbers are markedly reduced as a result of a T cell–intrinsic defect that is manifest
during thymocyte development. Although c-Rel is not essential for TGF- conversion of
peripheral CD4+CD25 T cells into CD4+Foxp3+ cells, it is required for optimal homeostatic
expansion of peripheral T reg cells. Despite a lower number of peripheral T reg cells in
c-rel/ mice, the residual peripheral c-rel/ T reg cells express normal levels of Foxp3,
display a pattern of cell surface markers and gene expression similar to those of wild-type
T reg cells, and effectively suppress effector T cell function in culture and in vivo. Collectively, our results indicate that c-Rel is important for both the thymic development and
peripheral homeostatic proliferation of T reg cells.
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Regulatory T (T reg) cells represent a class of
T lymphocytes that serve to restrict the extent
and duration of immune responses, as well as
maintain self-tolerance by suppressing autoreactive T cells (Shevach, 2000; Sakaguchi, 2004,
2005; Fontenot and Rudensky, 2005; Ziegler,
2006). Among the different types of T reg cells
described to date, CD4+CD25+ cells that express
the transcription factor Foxp3 are the most well
characterized T cells with immune-suppressive
properties (Fontenot and Rudensky, 2005;
Sakaguchi, 2005; Ziegler, 2006). Most Foxp3+
CD4 T cells, referred to as CD4 T reg cells, begin to develop in the thymus between 2 and 3 d
after birth (Fontenot et al., 2005a). Like conventional CD4+ T cells, thymus-derived
CD4+Foxp3+ T cells (also known as natural
T reg [nT reg] cells) undergo positive selection
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through TCR interactions with self-peptides
presented by cortical thymic epithelial cells
(Bensinger et al., 2001). Although conventional
CD4 single-positive (SP) T cells that express
TCRs with low to intermediate affinity for selfpeptides are selected to undergo maturation, and
those with high-affinity TCRs are eliminated by
negative selection (Robey and Fowlkes, 1994),
T reg cells appear to develop from CD4 SP thymocytes expressing TCRs with a relatively high
affinity for self-antigens (Caton et al., 2004;
Liston and Rudensky, 2007). In addition to
TCR signals, costimulatory molecules and cytokines, which include CD28 (Tang et al., 2003;
Sansom and Walker, 2006) and IL-2 (Bayer
et al., 2005; Fontenot et al., 2005b), respectively,
contribute to the development of nT reg cells.
Consistent with multiple signals being required
for nT reg cell development, disrupting various
© 2009 Isomura et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months
after the publication date (see http://www.jem.org/misc/terms.shtml). After six
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in number, residual c-rel/ T reg cells express normal levels of
Foxp3 and exhibit a phenotype similar to that of normal T reg
cells. Moreover, c-Rel appears to be dispensable for T reg cell
immune regulatory function in culture and in vivo. Collectively these findings indicate that c-Rel is a transcription factor
that regulates both the thymic development and peripheral homeostatic expansion of T reg cells.
RESULTS
Thymic and peripheral T reg cell numbers are markedly
reduced in c-rel/ mice
Conditional deletion of ikk2 in T lineage cells, which blocks
activation of the classical NF-B pathway, disrupts T reg cell
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intracellular signaling pathways engaged by these receptors impairs nT reg cell differentiation (Liston and Rudensky, 2007).
Although the majority of Foxp3+ T reg cells develop in the
thymus (Fontenot et al., 2005a), TGF- is also able to promote the differentiation of mature CD4+CD25Foxp3 peripheral T cells into CD4+CD25+Foxp3+ cells that possess T
cell suppressive properties akin to those of nT reg cells (Chen
et al., 2003; Marie et al., 2005).
Although the Foxp3 transcription factor is essential for
the T cell–suppressive properties of T reg cells (Fontenot et al.,
2003; Hori et al., 2003; Williams and Rudensky, 2007),
Foxp3 itself does not appear to be a T reg cell lineagedetermining transcription factor (Gavin et al., 2007; Lin et al.,
2007; Zheng and Rudensky, 2007). Instead, Foxp3 functions
by maintaining a pattern of T reg cell–specific gene expression that is controlled by other transcription factors (Marson
et al., 2007; Zheng and Rudensky, 2007; Zheng et al., 2007),
which, by inference, must dictate the lineage determination
of CD4+Foxp3+ T cells.
The Rel–NF-B pathway has been implicated in the
generation of T reg cells (Siebenlist et al., 2005; Liston and
Rudensky, 2007). The transcriptional mediators of this pathway comprise homodimers and heterodimers of five related
proteins (c-Rel, RelA, RelB, p50NF-B1, and p52NF-B2).
In the absence of stimulatory signals, Rel–NF-B factors are
retained in an inactive state within the cytosol by IB proteins (Hayden and Ghosh, 2008). Signals emanating from the
cell surface or intracellular receptors activate a multisubunit
IB kinase (IKK) that, upon phosphorylating IB, targets it
for proteosome-mediated degradation (Scheidereit, 2006),
thereby promoting the nuclear translocation of Rel–NF-B
factors. The classical arm of the NF-B pathway comprises
the IKK2 kinase and the transcription factors NF-B1, RelA,
and c-Rel (Gilmore, 2006), whereas the alternate NF-B
pathway requires the IKK1 kinase to activate NF-B2 and
RelB (Gilmore, 2006).
The alternate NF-B pathway is dispensable for T reg cell
development (Siebenlist et al., 2005), whereas inactivation of
IKK2 (Schmidt-Supprian et al., 2003) or the combined loss of
NF-B1 and c-Rel (Zheng et al., 2003) markedly reduces thymic and peripheral CD4+CD25+ cell numbers. Despite these
links between the classical NF-B pathway and the generation
of T reg cells, the specific roles of individual Rel–NF-kB transcription factors in T reg cell differentiation and function remain to be determined. In this paper, we report that c-Rel
is the critical NF-B transcription factor required to generate normal numbers of thymic and peripheral T reg cells.
Consistent with c-Rel being highly expressed in thymic T reg
cells, c-rel/ mice display diminished numbers of thymic
CD4+Foxp3+ T cells as a result of a thymocyte-intrinsic
survival-independent defect in T reg cell development. Although
c-Rel is not essential for TGF- conversion of CD4+CD25
T cells into CD4+CD25+FoxP3+ cells in culture or in vivo, the
reduced capacity of c-rel/ T reg cells to undergo homeostatic
expansion may contribute to the lower numbers of peripheral
T reg cells seen in c-rel/ mice. Despite a significant reduction

Figure 1. T reg cell populations in Rel–NF-kB–deficient mice. Single cell suspensions from the thymus, spleen, and lymph nodes of Rel–
NF-kB–deficient mice stained with antibodies for CD4, CD8, CD25, and
Foxp3 were examined by flow cytometry. Representative dot plots from
one of six independent experiments are presented with the percentage of
cells in the relevant quadrants indicated. (A and B) For every experiment,
organs from two mice of each genotype were analyzed separately.
(A) Expression profiles of CD4 versus CD8 and Foxp3 versus CD25 (gated
on CD4SP cells) for thymocyte populations in wt, nfkb1/, and c-rel/
(i) mice and irradiated recipients of wt or rela/ E14 fetal liver hemopoietic progenitors (ii). (B) Expression profiles of CD4 versus CD25 and Foxp3
versus CD25 (CD4 gated cells) for CD4 T cell populations in spleen and
lymph nodes of wt and c-rel/ mice. (C) Percentage and numbers of T
reg cells in the thymus, spleen, and lymph nodes of individual wt and crel/ mice. Each symbol represents an individual mouse. *, P < 0.05; **, P
< 0.02; ***, P < 0.01. The data were compiled from two independent experiments. Horizontal bars represent the mean values of the data.
NF-B and T reg cell development | Isomura et al.
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d iminished numbers of T reg cells in peripheral lymphoid
tissues, CD4+Foxp3+ populations were assessed in the spleen
and lymph nodes (Fig. 1 B). Whereas c-rel/ CD4+CD25
T cell numbers in both lymphoid compartments are normal
(Pohl et al., 2002), CD4+CD25+Foxp3+ T cells are reduced 3-fold. Loss of c-Rel also leads to a reduction in
CD4+CD25Foxp3+ T cells in these peripheral lymphoid
organs. A similar reduction in peripheral CD4+Foxp3+ T
cells is also observed in c-rel/ mice as old as 24 wk of age
(unpublished data). These findings, summarized in Fig. 1 C,
establish that c-Rel is required to generate normal numbers
of thymic and peripheral CD4+Foxp3+ T cells.
The T reg cell deficit in c-rel/ mice arises in neonates
Mouse CD4+Foxp3+ T cells first arise in the thymus within
2–3 d of birth (Fontenot et al., 2005a), and by day 5 (D5) sufficient T reg cells have been generated to protect mice from
developing autoimmune disease (Shevach, 2000; Sakaguchi,
2004, 2005; Fontenot and Rudensky, 2005). To determine if
the T reg cell deficit in c-rel/ mice occurs at the outset of
T reg ontogeny or develops as mice age, CD4+CD25+ and
CD4+Foxp3+ thymic populations were compared in wt and
c-rel/ D2 and D5 neonates, as well as 28-d-old mice. At D2,
the earliest time at which thymic Foxp3+ T cells are detectable
(Fontenot et al., 2005a), the percentage of CD4+CD25+
thymocytes (5–6% of CD4 SP cells) was similar in wt and
c-rel/ mice (Fig. 2 A). Although the CD4+Foxp3+ population is very low in D2 mice of both genotypes (Fig. 2 A and
Table S1), it was found to be smaller in c-rel/ mice (2.5%
vs. <0.02% of CD4+CD25+ thymocytes). By D5, despite an
increase in the absolute numbers (Table S1) of CD4+ Foxp3+
thymocytes in both wt and c-rel/ mice, the proportion of

Figure 2. Thymic and splenic T reg populations in wt and c-rel/ neonates. (A and B) Percentages of CD4+CD25+, CD4+CD25+Foxp3+, and
CD4+CD25Foxp3 thymocytes (A) and splenic T cells (B) as a proportion of CD4 SP cells in 2-, 5-, and 28-d-old wt and c-rel/ mice. Each symbol represents
an individual mouse. Data for individual mice were compiled from four independent experiments. Horizontal bars represent the mean values of the data.
JEM
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development (Schmidt-Supprian et al., 2003). This finding
prompted us to determine the roles of the individual transcriptional mediators of the classical Rel–NF-kB pathway,
namely p50NF-B1, RelA, and c-Rel, in T reg cell development. Initially, thymic CD4+Foxp3+ populations were examined in c-rel/ and nfkb1/ mice, as well as in lethally
irradiated Ly5.1+ C57BL/6 mice engrafted with embryonic
day 13 (E13) rela/ fetal liver hemopoietic stem cells
(Ly5.2+). The use of radiation chimeras is required to examine the role of RelA in T reg cell development as a result of
the death of rela/ embryos at E15 from fetal hepatocyte
apoptosis (Beg et al., 1995).
Total thymocyte cellularity and the relative frequencies of
CD4CD8, CD4+CD8+, CD4+CD8, and CD4CD8+
thymocytes in 6–8-wk-old mice are normal in the absence
of c-Rel, NF-B1, or RelA (Grossmann et al., 2000; Pohl
et al., 2002). However, the proportion of CD4+CD25+Foxp3+
thymocytes, although normal in nfkb1/ mice and 2.5fold lower in rela/ chimeras, are reduced 6–7-fold in
c-rel/ mice (Fig. 1 A). c-rel/ CD4+CD25-Foxp3+ thymocyte numbers are also reduced in similar proportions (Fig. 1 A, i)
but, interestingly, this population is slightly elevated in the
rela/ chimeras (Fig. 1 A, ii). Given that c-Rel appeared to
be the most important of the Rel–NF-kB transcription factors necessary for the generation of CD4+Foxp3+ thymocytes, subsequent work focused on the role of c-Rel in T reg
cell development and function.
The peripheral T reg cell population is mainly, but not
exclusively, derived from cells generated in the thymus
(Fontenot and Rudensky, 2005; Fontenot et al., 2005a;
Sakaguchi, 2005; Ziegler, 2006). To ascertain if fewer
CD4+Foxp3+ thymocytes in c-rel/ mice translate into

Published December 7, 2009

CD4+CD25+Foxp3+ cells in the CD4 SP thymocyte population remains four- to fivefold lower in c-rel/ mice (Fig. 2 A).
Unlike at D2, the difference in T reg cell numbers in these
mice at D5 was now also reflected in the relative proportion
of CD4+CD25+ thymocytes (5 vs. 3% in wt and c-rel/
mice, respectively; Fig. 2 A). A similar trend was also observed
in the CD4+CD25Foxp3+ thymocyte populations of D2 and
D5 neonates (Fig. 2 A). CD4+Foxp3+ (both CD25+ and
CD25) splenic T cells are also reduced in D5 c-rel/ neonates (Fig. 2 B) and these trends were replicated in the D28
thymic and spleen samples (Fig. 2 B). Together, these data indicate that the deficit of CD4+Foxp3+ T cells in c-rel/ mice

reflects a failure to generate normal numbers of these cells in
the thymus during neonatal development.
The reduction in c-rel/ T reg cells is caused
by a hemopoietic defect
The development of different T cell populations is dependent
on thymocyte interactions with other hemopoietic cells, including DCs, as well as nonhemopoietic stroma such as thymic epithelial cells (Takahama, 2006). Rel–NF-kB involvement in the
development and function of both hemopoietic (Gerondakis
et al., 2006) and epithelial cells (Pasparakis et al., 2002; Gugasyan
et al., 2004) prompted the generation of bone marrow chimeras

Downloaded from jem.rupress.org on December 10, 2009

Figure 3. The c-rel/ T reg cell deficit results from a thymocyte-intrinsic defect. (A) The c-rel/ T reg cell deficit arises from a cell-autonomous
defect. wt, c-rel/, or mixtures of equal numbers of wt (Ly5.1 and Ly5.2) or wt (Ly5.1) and c-rel/ (Ly5.2) bone marrow cells were engrafted into irradiated recipients (Ly5.2+ mice) and, 8 wk later, T reg cell populations were examined in thymus, spleen, and blood. Each symbol represents an individual
mouse. The data are representative of two independent experiments using similar numbers of mice in each experimental group. (B) The T reg cell deficit in
c-rel/ mice is the result of a hemopoietic defect. Irradiated wt and c-rel/ mice (Ly5.2) were engrafted with wt bone marrow (Ly5.1) and, 8 wk later,
donor-derived T reg cell (Ly5.1) numbers were determined in the thymus, spleen, and blood. Each symbol represents an individual mouse. The data are
representative of two independent experiments using similar numbers of mice in each experimental group. Horizontal bars represent the mean values of
the data. (C) Thymic DC-induced T reg cell differentiation in culture. wt and c-rel/ CD4+CD25 thymocytes and wt CD8Sirp+ DC cultured with IL-7 for
5 d were stained with antibodies for CD25 and Foxp3. The data shown is representative of two independent experiments. In both experiments, there were
duplicates for cultures using each combination of wt and c-rel/ thymocyte and DC. (D) Reduced T reg cell differentiation of c-rel/ CD4+CD8+ thymocytes in culture. Equal numbers of CD4+CD8lo cells generated in culture after anti-CD3 antibody activation of wt and c-rel/ CD4+CD8+ thymocytes expressing a Bcl-2 transgene (bcl2Tg) were stained with control or Foxp3 specific antibodies. The data shown is representative of three independent
experiments. In each experiment, the cultures for cells of each genotype were performed in triplicate.
 of 14
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to assess the contributions of the hemopoietic and stromal compartments to the reduction in c-rel/ T reg cells.
In irradiated wt (Ly5.1) recipients of c-rel/ bone marrow
(Ly5.2), the percentage and absolute number (not depicted)
of CD4+CD25+Foxp3+ thymocytes, like those in c-rel/
mice, were reduced compared with recipients of wt (Ly5.2)
bone marrow (Fig. 3 A). In contrast, the CD4+CD25+Foxp3+
thymic population was normal in the reciprocal bone marrow
donor/recipient combination where c-rel/ (Ly5.2) mice
were engrafted with Ly5.1+ wt bone marrow (Fig. 3 B). Similar conclusions were made for the T reg cell population in the
peripheral lymphoid tissues and blood of the chimeras (Fig. 3,
A and B). These experiments indicate that the thymic and
peripheral T reg cell deficiency in c-rel/ mice represents a
hemopoietic rather than a stromal defect.

The reduction in c-rel/ thymic T reg cells is not a result
of impaired survival
The role of c-Rel in promoting cell survival through the induction of genes encoding Bcl-2 prosurvival proteins (Gerondakis
JEM

Figure 4. Bcl-2 transgene expression fails to rescue the T reg cell
deficit in c-rel/ mice. CD4+CD8 thymocytes and CD4+CD25+ spleen
and lymph node cells from c-rel+/+bcl2Tg and c-rel/bcl2Tg mice were
stained with antibodies for CD25 and Foxp3. Representative dot plots
from an individual mouse of either genotype are presented with the percentage of cells in the relevant quadrants indicated. Two mice of each
genotype were analyzed in each experiment and the data are from one of
three independent experiments.
 of 14
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The defect in c-rel/ CD4 Foxp3+ thymocyte development
is thymocyte intrinsic
Despite bone marrow chimeras establishing that the c-rel/
T reg cell deficit is the result of a hemopoietic defect, these
experiments did not distinguish between defects intrinsic to
CD4+ thymocytes and defects in other hemopoietic cells involved in T reg cell differentiation. Two approaches were
used to address this question. First, chimeras were generated
by introducing an equal mix (1:1) of wt (Ly5.1) and c-rel/
(Ly5.2) bone marrow cells into irradiated wt (Ly5.2) recipients. The proportion of wt CD4+Foxp3+ cells in the thymus
and peripheral lymphoid organs was normal, yet the c-rel/
CD4+CD25+Foxp3+ and CD4+CD25-Foxp3+ (not depicted)
populations were reduced, resembling those in c-rel/ mice
or wt recipients of c-rel/ bone marrow (Fig. 3 A).
The second approach used cell culture models of thymic T
reg cell differentiation. In one model, CD4+CD25-Foxp3 thymocytes were cultured for 5 d with thymic CD8 Sirpa+ DC,
which preferentially converts these thymocytes into T reg cells
(Proietto et al., 2008). In these cultures, significantly more T reg
cells were generated from wt than c-rel/ CD4+CD25 thymocytes (Fig. 3 C). In another cell culture model, T reg cells were
generated by TCR and CD28 costimulation of CD4+CD8+
thymocytes (Tai et al., 2005). This method used wt and c-rel/
thymocytes expressing a Bcl-2 transgene to prevent the high
levels of CD4+CD8+ thymocyte apoptosis that normally accompanies TCR activation (Hettmann et al., 1999). After anti-CD3
plus anti-CD28 antibody activation, cells were cultured for an
additional 48 h, after which CD4+CD8lo cells were stained for
Foxp3 (Fig. 3 D). Despite TCR and CD28 stimulation generating similar frequencies of wt and c-rel/ CD4+CD8lo T cells,
Foxp3+ cell numbers were 3-fold lower in the c-rel/
CD4+CD8lo population. Together, these experiments establish
that c-rel/ thymocytes have an intrinsic defect in their capacity
to differentiate into T reg cells.

and Strasser, 2003) raised the possibility that a survival defect
might account for the reduced number of c-rel/ thymic or
peripheral T reg cells. This was assessed by introducing a bcl-2
transgene (bcl-2Tg) under the control of the hemopoieticrestricted vav promoter (Ogilvy et al., 1999) onto the c-rel/
background. The bcl-2Tg increased overall thymocyte cellularity
in wt and c-rel/ mice compared with nontransgenic counterparts (not depicted), yet bcl-2Tg expression did not correct the
selective reduction in c-rel/ CD4+CD25+Foxp3+ thymocytes
(Fig. 4). Although bcl-2Tg expression led to an increase in the
proportion of CD4+CD25Foxp3+ thymocytes in both wt and
c-rel/ mice when compared with nontransgenic counterparts
(compare Fig. 4 and Fig. 1 A), the frequency of this Foxp3+
population remained lower in c-rel/bcl-2Tg compared with
c-rel+/+bcl-2Tg mice (Fig. 4). This indicated that Bcl2 expression has a differential impact on the CD4+CD25+Foxp3+ and
CD4+CD25+Foxp3+ thymocyte populations. An examination
of the CD4+Foxp3+ populations in the spleen and lymph nodes
of c-rel+/+bcl-2Tg and c-rel/bcl-2Tg mice revealed a similar
picture to that seen in the thymus, with enforced Bcl-2 expression failing to rescue the diminished c-rel/ CD25+Foxp3+
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population (Fig. 4). Collectively, these data show that the reduced number of CD4+Foxp3+ cells in c-rel/ mice is not the
result of a defect in the Bcl-2 survival pathway.

c-Rel is required for the homeostatic proliferation
of peripheral T reg cells
Although thymus-derived CD4+Foxp3+ T cells are the major
source of T reg cells (Fontenot and Rudensky, 2005; Fontenot
et al., 2005a; Sakaguchi, 2005; Ziegler, 2006), the TGF-–
induced differentiation of CD4+CD25 T cells into T reg cells
(Chen et al., 2003; Marie et al., 2005), coupled with T reg cell
proliferation, collectively determines the size of the peripheral
T reg cell population. To determine if c-Rel is necessary for
TGF-–dependent conversion of CD4+CD25 T cells into T
reg cells, wt and c-rel/ CD4+CD25 T cell cultures were initially subjected to TCR activation in the absence or presence of
TGF-. Given that IL-2 enhances the generation of TGF-–
induced T reg cells in culture by promoting T cell proliferation
(Kretschmer et al., 2005) and TCR-mediated CD4+CD25
T cell proliferation requires the c-Rel dependent expression of
IL-2 (Köntgen et al., 1995; Rao et al., 2003), the influence of
IL-2 on TGF-–induced c-rel/ T reg cell differentiation was
also determined (Fig. 6 A).
Without TGF-, 1% of activated wt and c-rel/ cells
were Foxp3+. In the absence of IL-2, this increased to 33%
for cells of both genotypes in the presence of TGF- (Fig. 6 A).
 of 14
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c-Rel is up-regulated in thymic T reg cells
The reduction in c-rel/ thymic T reg cells resulting from a
thymocyte intrinsic defect raised the issue of c-Rel expression
during thymopoiesis and how this might relate to T reg cell
development. This was determined by Western blot analysis
of c-Rel expression in total cell lysates from CD4+CD8+,
CD4CD8+, CD4+CD25, and CD4+CD25+ thymocytes
(Fig. 5 A). Whereas c-Rel is barely detectable in CD4+CD8+
cells and its expression is only marginally higher in CD4-CD8+
and CD4+CD25 thymocytes, c-Rel levels, like those of
Foxp3, are dramatically elevated in the CD4+CD25+ population. RelA levels in contrast do not differ between CD4+CD25
and CD4+CD25+ thymocytes (Fig. 5 A). Consistent with the
protein expression data, real-time PCR confirmed that c-rel,
but not rela, messenger RNA (mRNA) is specifically upregulated in CD4+CD25+ thymocytes (Fig. 5 B). nfkb1
mRNA levels are also somewhat elevated in CD4+CD25+
thymocytes compared with CD4+C25 cells. These findings,
coupled with the phenotype in c-rel/ mice, indicated that
high levels of c-Rel may be necessary for the maintenance of
the T reg cell population. Surprisingly, Western blotting of
cytosolic and nuclear fractions from wt CD4+CD25+ thymocytes revealed that c-Rel could only be detected in the cytosol
(Fig. 5 C), indicating that constitutive c-Rel activation does
not appear to be essential for the maintenance of thymic T reg
cells. The expected pattern of c-Rel expression in the cytoplasm and nucleus of resting and activated B cells (Fig. S1)
validated the accuracy of the fractionation process used to
examine T reg cells.

After the addition of IL-2 during TGF-–induced T reg cell
differentiation, the proportion of cultured wt and c-rel/
CD4+Foxp3+ T cells increased to between 93 and 95%
(Fig. 6 A). Although the frequency of TGF-–generated wt and
c-rel/ Foxp3+ cells was similar, absolute numbers of c-rel/
Foxp3+ cells recovered in culture were two- to threefold lower
than for wt Foxp3+ cells, irrespective of whether IL-2 was present (Fig. S2). This reduced number of c-rel/Foxp3+ cells reflects a decrease in c-rel/ CD4+ T cells recovered after TGF-
stimulation (Fig. S2) that coincides with diminished TCRmediated c-rel/ T cell proliferation (Fig. S3).

Figure 5. c-Rel is highly expressed in thymic T reg cells. (A) Western
blot analysis of c-Rel, RelA, and Foxp3 expression in different thymocyte
populations. Western blot analysis of total cell lysates was used to determine c-Rel and Foxp3 expression in purified wt populations of CD4CD8+,
CD4+CD8+, CD4+CD25, and CD4+CD25+ thymocytes and RelA expression
in wt CD4+CD25 and CD4+CD25+ thymocyte populations. ERK or actin
expression served as loading controls. The data are representative of two
independent experiments using different lysate samples prepared from
thymocyte populations purified from the pooled thymi of three mice for
each experiment. (B) c-rel, rela, and nfkb1 mRNA levels in thymocyte populations. The levels of c-rel, rela, and nfkb1 mRNA expressed in purified
CD4+CD25+ and CD4+CD25 thymocyte populations were determined by
real-time PCR. The data represents duplicate PCRs performed on individual
samples from each of four independent sets of cells. Error bars represent
SEM. (C) c-Rel is localized in the cytoplasm of thymic T reg cells. Nuclear
and cytoplasmic fractions from purified CD4+CD25+ thymocytes were subjected to Western blotting analysis using antibodies for c-Rel, ERK, and
histone H3. The data shown is representative of two independent experiments using different preparations of nuclear and cytoplasmic lysates.
NF-B and T reg cell development | Isomura et al.
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The conversion of c-rel/ CD4+CD25- T cells into
CD4+Foxp3+ cells in vivo was also examined (Curotto de
Lafaille et al., 2004; Almeida et al., 2006). The relative efficiency with which a T reg cell population develops from
c-rel/ CD4+CD25- cells was determined by injecting a
1:1 ratio of wt (Ly5.1) and c-rel/ (Ly5.2) CD4+CD25 T
cells into rag-1/ mice. 18 d later, the number (Fig. 6 B)
and frequency (Fig. S4) of CD4+Foxp3+ cells from each do-
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Figure 6. The roles of c-Rel in T reg cell conversion and homeostatic expansion. (A) TGF- induced differentiation of c-rel/ T reg cells
in culture. wt and c-rel/ splenic CD4+CD25 T cells incubated with antiCD3 antibodies and irradiated T cell–depleted allophycocyanin (APC) in
the absence or presence of TGF- (with or without IL-2) for 4 d were
stained with antibodies specific for CD25 and Foxp3. Representative dot
plots from one of four independent experiments are presented with the
percentage of cells in the relevant quadrants indicated. In each experiment, there were triplicate cultures for each set of stimulation conditions.
(B) T reg cell conversion in vivo. Mesenteric lymph node (MLN) cells isolated from rag-1/ mice injected 18 d earlier with either a 1:1 mix of
purified splenic CD4+CD25 wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) and crel/ (Ly5.2+) T cells were stained with antibodies specific for CD4, CD8,
CD45.1 (Ly5.1), and Foxp3. The data compares the absolute numbers of wt
(Ly5.1+ and Ly5.2+, squares and circles, respectively) and c-rel/ (Ly5.2+,
triangles) CD4+Foxp3+ cells detected in the mesenteric lymph nodes of
individual mice receiving each mixture of cells. Horizontal bars represent
the mean values of the data. Error bars represent SD. The data were analyzed using a paired Student’s t test and is representative of two independent experiments, with a minimum of five mice in each recipient group.
(C). c-Rel is necessary for optimal homeostatic expansion of T reg cells in
lymphopenic mice. MLN cells isolated from rag-1/ mice injected between 4 and 8 wk earlier with either a 1:1 mix of purified wt (Ly5.1+,
squares; Ly5.2+, circles) or wt (Ly5.1+, squares) and c-rel/ (Ly5.2+, triangles) splenic CD4+CD25+ T cells were stained with antibodies specific
for CD4, CD8, CD45.1 (Ly5.1), and Foxp3. The data shows the number of
MLN T reg cells of each donor type in recipient mice (six per group) from
one experiment. The data shown is representative of three independent
experiments with five or six mice in each recipient group.

nor population in the lymph nodes of individual mice was
compared using paired data analysis. Although naive c-rel/
CD4+CD25 T cells can convert to T reg cells in vivo, the
absolute number and percentage of c-rel/ T reg cells was
reduced when compared with the wt population.
To determine if the impaired T reg cell proliferation observed in culture also occurs in vivo, we examined the homeostatic expansion of c-rel/ T reg cells under competitive
conditions in a lymphopenic host. A 1:1 mix of wt (Ly5.1+
and Ly5.2+) or wt (Ly5.1+) and c-rel/ (Ly5.2+) CD4+CD25+
T cells was introduced into rag-1/ mice, and between
4 and 12 wk later the number of T reg cells in lymph nodes
from the different donors was determined. In contrast with

Figure 7. Foxp3, CD25, CTLA4, and GITR expression in thymic and
splenic CD4+CD25+ and CD4+CD25+Foxp3+ T cells. (A and B) wt and
c-rel/ CD4+CD25+ thymocytes (A) and splenocytes (B) were stained with
antibodies for Foxp3, CD25, CTLA4, or GITR. Representative profiles from
one of five independent experiments are shown for wt (line) and c-rel/
(dashed line) cells stained with control (filled) and test (open) antibodies.
In each experiment, a single mouse of each genotype was used. (C) Relative mRNA levels for foxp3, cd25, ctla4, and gitr were determined by
RT-PCR from purified populations of wt (closed) and c-rel/ (open) CD4SP,
CD4+CD25+, and CD4+CD25 thymocytes. The data represents the mean
value from duplicate PCRs performed on individual samples from each of
three independent sets of cells.
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control mice, which retain a similar ratio of wt Ly5.1+ and
Ly5.2+ T reg cells to the starting populations after homeostatic expansion, the number of c-rel/ T reg cells was always
significantly less compared with cotransferred wt T reg cells
(Fig. 6 C). This indicates that the capacity of c-rel/ T reg
cells to undergo homeostatic expansion is reduced.

Table I. Comparison of mRNA levels in CD4SPCD25+ and
CD4SPCD25 thymocytes in WT and c-rel/ mice
Gene name

I110
Ebi3
Tnfrsf9 (41BB)
Nt5e (CD73)
Tnfrsf4 (Ox40)
Map3k8
Crem
Bc1211
Irf4
117r (CD127)
Cd401g
Bc12

Fold enrichment in
CD4SPCD25+ compared
with CD4SPCD25
thymocytes

Fold change in
CD4SPCD25+
thymocytes between WT
and c-rel/ mice

63
31.25
26.6
7.9
6.9
3.2
2.8
2.75
2.25
0.31
0.28
0.22

0.23
0.38
0.46
0.55
0.53
0.17
0.09
0.54
0.33
1.8
3.1
3.0

Values given for fold enrichment and fold change are means of at least two
independent biological replicates with duplicate PCRs performed for each experiment.
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c-Rel is not required for T reg cell function in culture
To evaluate the immune suppressive properties of c-rel/ T
reg cells, we first determined their capacity to inhibit CD4+ effector T cell proliferation in culture. Initially, suppression assays
were performed using spleen and lymph node CD4+CD25+
T cells isolated from wt and c-rel/ mice. In these assays,
c-rel/ T reg cells were found to be slightly less effective at
suppressing T cell proliferation than wt T reg cells (Fig. 8 A).
Given that the frequency of Foxp3+ cells in the c-rel/
CD4+CD25+ T cell population was slightly less compared
with wt CD4+CD25+ T cells (Fig. 7 B and Fig. S5), to determine if the reduced suppressive capacity of c-rel/ CD4+CD25+
splenic T cells simply reflected fewer numbers of Foxp3+ T reg
cells in this population, we also examined the suppressive
properties of c-rel/ T reg cells generated in culture. First, wt
and c-rel/ CD4+CD25- T cells were transduced with retroviruses coexpressing gfp and murine foxp3. Greater than 96% of
wt and c-rel/ T cells infected with the GFP-Foxp3 virus expressed Foxp3, and Western blotting confirmed that its levels
were equivalent in both groups of cells (Fig. S5). Whereas
T cells infected with a GFP-only control virus failed to suppress CD4+CD25 T cell proliferation (not depicted), both
wt and c-rel/ GFP+Foxp3+ T cells were equally effective at
inhibiting T cell proliferation (Fig. 8 B). wt and c-rel/
CD4+CD25+ T cells generated by stimulating activated
CD4+CD25 T cells with TGF- plus IL-2 (both 97–98%
Foxp3+; Fig. S5) were also found to be equally effective at suppressing T cell proliferation (Fig. 8 C). Collectively, these data
indicate that in culture c-Rel is dispensable for the immune
suppressive properties of T reg cells.

c-rel/ T reg cells inhibit T cell–dependent colitis
To determine if c-rel/ T reg cells can inhibit T cell–mediated
autoimmune disease, we used a model of T cell–dependent
colitis induced in Rag-deficient mice after the adoptive transfer of CD4+CD25CD45RBhi T cells that can be prevented
by cotransferring T reg cells (Asseman et al., 1999).
CD4+CD25CD45RBhi T cells (4 × 105) were injected into
rag-1/ mice alone or with 105 wt or c-rel/ CD4+CD25+
T cells. Mice were monitored for signs of illness (weight loss
and diarrhea) over a 10-wk period. All sick mice and any remaining healthy mice were euthanized and histological analysis of colon sections performed. Whereas all mice injected
with only CD4+CD25CD45RBhi T cells developed colitis,
NF-B and T reg cell development | Isomura et al.

Downloaded from jem.rupress.org on December 10, 2009

Phenotypic properties of c-rel/ CD4+ T reg cells
Although c-Rel is necessary for generating normal numbers
of thymic and peripheral T reg cells, it was unclear what impact the absence of c-Rel had on the phenotype of the remaining T reg cells. This issue was addressed by comparing
the mRNA and protein expression of various characteristic
T reg cell markers in wt and c-rel/ CD4+CD25+ thymocytes
and splenic T cells (Fig. 7). Real-time PCR and intracellular
staining established that the levels of Foxp3 expression are
equivalent in wt and c-rel/ CD4+CD25+ thymocytes and
splenic T cells (Fig. 7, A and C). This indicates that c-Rel does
not control Foxp3 expression. Although CD25 and CTLA4
protein expression is normal in c-rel/ thymic and splenic T reg
cells, glucocorticoid-induced TNF receptor–related (GITR)
protein levels are marginally lower on c-rel/ CD4+CD25+
thymocytes but not c-rel/ CD4+CD25+ splenic T cells (Fig. 7,
A and B). These data are also borne out by mRNA analyses
(Fig. 7 C and not depicted).
Genes expressed in CD4+ T cells, including those relevant
to CD4+Foxp3+ T reg cell function (Marson et al., 2007;
Zheng et al., 2007) and genes known to be c-Rel targets
(Bunting et al., 2007), were also examined by real-time PCR
(Table I). As expected, a group of these genes were enriched
in the thymic or splenic CD4+CD25+ population compared
with the CD4+CD25 population (Table I). Several of these
genes, including Il10, 41BB, CREM, MAP3K8, Irf4, Bcl2l1,
Ox40, and Ebi3, showed a decrease in expression (generally

2–3-fold) in c-rel/ CD4+CD25+ thymocytes compared
with WT CD4+CD25 thymocytes (Table I). Expression of
a smaller number of the genes examined, namely CD127,
CD40L, and Bcl2, was decreased in the thymic CD4+CD25+
population compared with CD4+CD25 cells (Table I), and,
interestingly, expression of several of these genes were increased in the absence of c-Rel (Table I) . In contrast, loss of
c-Rel did not significantly influence gene expression patterns
in splenic CD4+CD25+ T cells (unpublished data). Therefore,
we conclude that c-Rel appears to have a role in modulating
the gene expression profile of thymic CD4+CD25+ cells.
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no histological evidence of colitis was observed in animals
that had also received wt or c-rel/ splenic T reg cells (Fig. 8,
D and E). This indicates that c-Rel is dispensable for the
immune suppressive function of T reg cells in this model of
autoimmune disease.

Figure 8. c-rel/ T reg cells inhibit T cell proliferation in culture and suppress CD4 T cell-dependent colitis. Varying numbers of wt and
c-rel/ T reg cells (suppressors) from various sources (see A–C) incubated in culture with a fixed number of wt splenic CD4+CD25 T cells (effectors),
expressed as a ratio, were activated with anti-CD3 antibodies and irradiated T cell–depleted APC for 72 h. Proliferation was monitored by 3H-thymidine
incorporation. The data shown in A–C is the SEM for four independent experiments using each different source of T reg cells. Every data point was performed in triplicate for each experiment. (A) Splenic T reg cells from wt and c-rel/ mice. (B) Foxp3+ cells generated by transducing wt and c-rel/
CD4+CD25 splenic T cells with GFP-Foxp3 retroviruses. (C) Foxp3+ cells generated from TGF- + IL-2–treated wt and c-rel/ CD4+CD25 splenic T cells.
rag-1/ mice injected with CD4+CD45RBhi T cells (4 × 105) in the absence or presence of wt or c-rel/ CD4+CD25+ T cells (105, >87% Foxp3+) were monitored regularly for up to 10 wk. During this period, mice displaying signs of illness or weight loss were sacrificed. After 10 wk, the remaining mice were
weighed and sacrificed. The colons were removed from all mice and processed for histology. (D) Representative hematoxylin and eosin–stained colon
sections from rag-1/ mice receiving CD4+CD45RBhi T cells alone or with wt or c-rel/ CD4+CD25+ T cells (n = 12 mice for each cohort). Bars, 875 µM.
(E) Histology scores for rag-1/ mice receiving CD4+CD45RBhi T cells alone or with wt or c-rel/ CD4+CD25+ T cells based on a modification of Berg
et al. (1996). *, P < 0.02; **, P < 0.05.
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DISCUSSION
Little is currently known about the roles of the classical
NF-B pathway in the development or function of T reg
cells. In this paper, we show that among the transcription factors operating downstream of this pathway, c-Rel is the most
important for T reg cell development. T cell–intrinsic expression of c-Rel, although necessary for generating normal numbers of thymic T reg cells, is not essential for TGF-–mediated
T reg cell differentiation. Despite a need for c-Rel during nT
reg cell development and peripheral T reg cell homeostasis, crel/ T reg cells effectively suppress CD4+ effector T cell
proliferation in culture and prevent the induction of colitis in
rag1/ mice engrafted with CD4+CD45RBhi T cells. These

findings support a model in which the development of T reg
cells in the thymus and maintenance of the T reg cell phenotype have distinct molecular requirements, with c-Rel belonging to that class of transcription factors whose function is
important in regulating thymic T reg cell differentiation.
Previously, nonredundant roles for c-Rel in the T cell lineage were thought to be restricted to mature T cells and involve
functions such as proliferation, survival, and cytokine production (Gerondakis et al., 2006). In this paper, we establish that
c-Rel is required during thymic T reg cell development, with
the absence of c-Rel leading to a marked reduction in both
CD4+CD25+Foxp3+ and CD4+CD25Foxp3+ thymocytes.
The importance of c-Rel being expressed in thymic T reg cells
during their development, as opposed to thymic stromal cells or
other hemopoietic cells such as DC, was confirmed using mixed
bone marrow chimeras and cell culture models of T reg cell
differentiation. Consistent with this conclusion, c-Rel expression is markedly elevated in thymic T reg cells compared with
conventional CD4 or CD8SP thymocytes.
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c-Rel is not required for TGF-–dependent differentiation of CD4+CD25 T cells into Foxp3+ T reg cells in culture, nor is it essential for T reg cell conversion in vivo.
Although the size of the T reg cell population that arises in a
lymphopenic environment from c-rel/ CD4+CD25 T cells
is reduced when compared with wt cells, it remains unclear
whether this reflects a genuine defect in the efficiency with
which conversion occurs in vivo or whether it is simply the
result of the impaired proliferation of the converted T reg
cells, which is controlled by c-Rel. So although a failure to
produce normal T reg cell numbers in the thymus almost
certainly accounts for some of the peripheral T reg cell deficit
in c-rel/ mice, the reduced capacity of c-rel/ T reg cells to
undergo normal homeostatic expansion is also likely to contribute to the overall reduction in peripheral c-rel/ T reg
cell numbers.
Despite being reduced in number, the remaining thymic
c-rel/ T reg cells, as assessed by key T reg cell marker expression, appear relatively normal. Foxp3 mRNA and protein
levels are unchanged, as is the expression of characteristic
T reg cell markers such as CTLA4, CD25, CD37, and CD73.
Similar findings were made for splenic and lymph node T reg
cells from c-rel/ mice, plus c-rel/ T reg cells generated in
culture either by TGF- treatment or enforced Foxp3 expression (unpublished data). Nevertheless, the expression of several genes was found to be lower or higher (2–3-fold in
most instances) in c-rel/ CD4+CD25+ thymocytes but not
in peripheral T reg cells, which is consistent with the main
role of c-Rel in the generation of thymic Foxp3+ cells. These
differences point to c-Rel serving as a modulator of transcription in thymic T reg cells, which is consistent with its role
in other cell types, including CD4+CD25 effector T cells
(Bunting et al., 2007). It remains to be determined whether
these differences in gene expression identified to date contribute
to the reduction in c-rel/ thymic T reg cell numbers.
Residual c-rel/ T reg cells can inhibit CD4 effector
T cell proliferation in culture and, importantly, prevent colitis in rag1/ mice engrafted with CD4+CD45RBhi T cells.
This indicates that the immune modulatory function of the
remaining c-rel/ T reg cells appears to be relatively normal.
The remaining T reg cells in c-rel/ mice also appear to be
sufficient in number and activity to control antigen-dependent T cell effector responses. T reg depletion in vivo by
anti-CD25 antibody administration increases the frequency
of influenza virus-specific CD8 cytotoxic T cells in mice
during the primary immune response (Haeryfar et al., 2005).
Nevertheless, the number of influenza virus–specific CD8 effector T cells induced in the spleen and lungs of influenza virus infected c-rel/ mice is normal (Harling-McNabb et al.,
1999). Similarly, although the OVA-induced proliferation of
OT-I TCR transgenic T cells is enhanced after T reg depletion (Salem et al., 2007; Fig. S6 A), the expansion of antigenstimulated OT-I CD8 T cells is equivalent in wt and c-rel/
mice (Fig. S6 B; Mintern et al., 2002). Although these findings indicate that there are sufficient T reg cells that function
relatively normally in c-rel/ mice to prevent the development
NF-B and T reg cell development | Isomura et al.
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Current models of thymic T reg cell differentiation favor
a multistep process controlled by TCR, costimulatory, and
cytokine signals, each of which is required during specific
stages of development (Liston and Rudensky, 2007). Given
that TCR and CD28 signaling are both crucial for T reg
cell development (Liston and Rudensky, 2007), with c-Rel
functioning downstream of both receptors in conventional
CD4+ T cells (Venkataraman et al., 1995; Kahn-Perlès et al.,
1997), c-Rel could conceivably control thymic T reg cell
differentiation at a single or multiple points. Although our
data demonstrates that a proportion of CD25+Foxp3 CD4SP
thymocytes, a population enriched for T reg cell precursors
(Lio and Hsieh, 2008), appears relatively normal at the onset
of T reg cell development in c-rel/ neonates, we cannot
rule out that the generation of the CD25+Foxp3 T reg cell
precursor population in c-rel/ mice is not affected. Alternatively, given that Foxp3+ T reg thymocytes are markedly diminished in 5-d-old c-rel/ neonates, c-Rel may promote
the development of T reg cells arising from a CD25+Foxp3
CD4SP precursor or control the expansion of T reg cells
once differentiation is complete. Although the differentiation
of T reg cells from a CD4+CD25+Foxp3 precursor is IL-2
dependent (Bayer et al., 2005; Fontenot et al., 2005b) and
c-Rel regulates il2 transcription in conventional CD4 T cells
(Köntgen et al., 1995; Rao et al., 2003), the inability of
mixed bone marrow chimeras to reverse the thymic c-rel/
T reg cell deficit indicates that it is not the result of a failure
to express IL-2 or other soluble factors. Furthermore, the inability of a Bcl-2 transgene to reverse the c-rel/ T reg cell
deficit rules out a role for c-Rel in controlling thymic T reg
cell survival during or after differentiation, a function served
by c-Rel in several other cell types (Gerondakis and Strasser,
2003; Gerondakis et al., 2006). Recent studies (Barnes et al.,
2009; Molinero et al., 2009) have demonstrated that mice
lacking functional CARMA1, a component of the CMB
(CARMA1–Bcl10–Malt1) TCR adaptor complex required
for NF-B activation (Lin and Wang, 2004), also have markedly reduced numbers of thymic T reg cells. Although
CARMA1 is required for both TCR-dependent NF-B and
JNK2 activation (Barnes et al., 2009), the finding that the
T reg cell deficit in CARMA mutant mice, like the c-rel/
mice, arises from a T cell–intrinsic defect that is independent
of Bcl-2 prosurvival signals (Barnes et al., 2009; Molinero
et al., 2009), provides strong support for a model in which
the TCR-dependent activation of c-Rel via CARMA1 is
important in T reg cell development.
The intriguing finding that c-Rel is cytosolic rather than
nuclear in thymic T reg cells lends support to the notion that
c-Rel is required for the differentiation rather than the maintenance of T reg cells. However, sustained expression of c-Rel in
thymic and splenic (unpublished data) T reg cells points to the
likelihood that c-Rel serves additional functions in these cells
in response to other signals. It remains to be determined what
types of stimuli, which could include antigen, costimulatory,
and cytokine signals, promote the nuclear expression of c-Rel
in T reg cells once differentiation in the thymus is complete.
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of autoimmune disease and limit effector T cell activity during certain immune responses, it remains a possibility that
defects in other c-rel/ cells, such as effector T cells or DC,
also contribute to the failure of autoimmune disease to develop in these mice.
Collectively, the data presented in this paper indicates
that c-Rel belongs to a class of transcription factors required
for thymic T reg cell differentiation and peripheral homeostatic proliferation but not the immune function of mature
T reg cells. However, this needs to be confirmed by examining the function of c-rel/ T reg cells across the gamut of
immune responses controlled by T reg cells.

Generation and analysis of radiation bone marrow chimeras. Bone
marrow cells (2 × 107) isolated from the femurs of wt or c-rel/ mice were injected into 8-wk-old lethally irradiated (2 × 550 Rad) recipients. The different
combinations of bone marrow chimeras were wt or c-rel/ (both Ly5.2) bone
marrow transferred into wt (Ly5.1) mice; wt (Ly5.1) or c-rel/ (Ly5.2) bone
marrow transferred into c-rel/ (Ly5.2) mice; and a 1:1 mix (107 cells each) of
wt (Ly5.1) and c-rel/ (Ly5.2) bone marrow injected into wt (Ly5.1) mice.
Reconstitution of the hemopoietic compartment with donor stem cells was
assessed 6 wk after transplantation by examining peripheral blood collected
from the retroorbital vein. T reg cells from the thymus and spleen of successfully engrafted mice were analyzed 8 wk after transplantation.

Mice. C57BL/6 mice (Ly5.1 and Ly5.2) were used as wt controls. c-rel/
(Köntgen et al., 1995), nfkb1/(Sha et al., 1995), rela+/(Beg et al., 1995),
rag-1/, vav-bcl-2 transgenic (bcl-2Tg; Ogilvy et al., 1999), and c-rel/bcl-2Tg
(Grumont et al., 2002) mice are all on a C57BL/6 background (Ly5.2, N:
9–12 backcrossed generations; rela+/, 35 backcrossed generations). OT-I
(C57BL/6) mice were on a Ly5.1 background. With the exception of E14
rela+/+, rela+/, and rela/ embryos used for fetal liver hemopoietic cell engraftment of irradiated recipients and neonates used for ontogeny studies, all
other experimental mice were used between 7 and 10 wk of age. Genotypes
of embryos from rela+/ intercrosses were determined by PCR. All animal
protocols were approved by the Research Directorate of Melbourne Health,
the Animal Ethics Committee of the Australian National University, and the
University of Queensland Animal Ethics Committee.

Isolation of thymic DC. Pooled thymuses were used for DC extraction as
described elsewhere (O’Keeffe et al., 2005). In brief, single cell thymic suspensions prepared by mechanical processing and collagenase digestion were treated
with EDTA. Light density cells were then collected by centrifugation and
non-DC lineage cells depleted using magnetic beads coupled to anti–rat-IgG
after coating them with rat anti–mouse anti-CD3, anti-CD90, anti-TER119,
anti-RB68C5, anti-CD19, anti-CD11b, and anti-F4/80. For conventional
DC isolation, enriched preparations were stained with anti-CD11c-FITC,
anti-CD8-PE, anti-CD45RA-APC, and anti–Sirp-biotin plus SA-PE-Cy7.
Conventional DCs with high forward scatter and bright staining for CD11c
were then separated into CD8+Sirp and CD8Sirp+ populations. The purity of the sorted DC was >98%.

Reagents. The following antibodies were used: biotin, PE, APC, or Cy5conjugated anti-CD4 (GK1.5), anti–mouse biotin-conjugated anti-CD3
(145-2C11), FITC-conjugated anti-CD25 (PC61.1), PE-conjugated antiGITR (DTA-1), PE-conjugated anti–CTLA-4 (UC10-4B9), and PE- or
APC-conjugated anti–mouse Foxp3 (FJK-16S). Streptavidin-conjugated PECy5 and PE-conjugated CD45RB (C363.16A) were purchased from eBioscience. Streptavidin-peridinin chlorophyll-a protein (SA-PerCP) was obtained
from BD. PE-conjugated CD25 (7D4) anti-biotin microbeads were obtained
from Miltenyi Biotec. TGF- and recombinant murine IL-2 were purchased
from R&D Systems and PeproTech, respectively. Dulbecco’s Modified Eagle
Medium supplemented with 10% FBS was used for cell culture.
Isolation of CD4+CD25+ and CD4+CD25 T cells. CD25+ and CD25
CD4SP thymocytes were purified by first using an enrichment step that
involved depleting anti–CD8-biotin–labeled CD8+ cells with anti-biotin
microbeads (Miltenyi Biotec), after which the unbound flow-through fraction stained with anti–CD4-PE, anti–CD8-biotin plus SA-PE-Cy5, and
anti–CD25-FITC was sorted for CD4+CD25+ and CD4+CD25 thymocytes using a MoFlo (Dako). T reg cells in spleen and lymph nodes were isolated from wt and c-rel/ mice by preenriching cell suspensions stained with
biotinylated anti-CD4 using anti-biotin magnetic beads (Miltenyi Biotec),
followed by staining with anti–CD4-PE and anti–CD25-FITC and sorting
for CD4+CD25+ and CD4+CD25 T cells. The purity of sorted CD4+CD25+
T cells was typically >96%.
Flow cytometric analysis. T cells in single cell suspensions of thymus,
spleen, and lymph nodes prepared from wt and c-rel/ neonates (D2 and D5)
or adult mice were stained with anti–CD4-APC and anti–CD25-FITC antibodies. Thymocytes were also stained with biotinylated anti-CD8 antibodies
and SA-PerCP. Intracellular Foxp3 stains were then performed using PEconjugated anti-Foxp3 antibodies (eBioscience). In some experiments, intracellular staining with anti–CTLA-4–PE antibodies was performed after surface
staining cells for CD4, CD25, CD8, GITR, and Foxp3 (APC-conjugated
Foxp3 antibodies). Stained cells were analyzed using a FACSCalibur (BD) or
LSR (BD), and the data was analyzed using CellQuest Pro software (BD).
JEM

Generation of thymic T reg cells in culture. T reg cell differentiation
in culture was performed using two methods. The first approach involved
coculturing different combinations of purified wt thymic CD8Sirp+ DC
(104 cells) with CD4+CD25 (2 × 104) thymocytes from wt or c-rel/ mice
in the presence of IL-7 for 5 d (Proietto et al., 2008). T reg cells were identified by staining with anti–CD4-Cy5, anti–CD25-FITC, and Foxp3-PE antibodies. The second culture method (Tai et al., 2005) involves activating wt
or c-rel/ CD4+CD8+ thymocytes (106) isolated from c-rel+/+bcl-2Tg and
c-rel/bcl-2Tg mice with 10 µg/ml of plate-bound anti-CD3 and 10 µg/ml
of anti-CD28 antibodies for 24 h, followed by an additional 48-h in culture
without activation, after which CD4+CD8lo cells were stained for Foxp3 as
described in this section.
Quantitative RT-PCR. Total RNA was extracted from sorted thymic and
splenic CD4+, CD4+CD25+, and CD4+CD25 T cells using TRI reagent
(Sigma-Aldrich) according to the manufacturer’s specifications. Total RNA
was DNase treated in 20 mM Tris, pH 8.3, 50 mM KCl, and 2 mM MgCl2
using 1 U RNase-free DNase I (Roche) per 1 µg of total RNA at 37°C for
30 min, followed by heat inactivation at 75°C for 5 min. 0.2–1 µg DNasetreated total RNA was reverse transcribed using the first-strand complementary
DNA (cDNA) synthesis system (OriGene) according to the manufacturer’s instructions. Quantitative real-time PCR was performed using an ABI PRISM
7500 or 7900HT sequence detection system (Applied Biosystems). Reactions
were performed in MicroAmp Optical 96-well or 384-well reaction plates (Applied Biosystems) in a final volume of 20 or 10 µl, respectively, containing
SYBR Green Master Mix (Applied Biosystems), 300 nM of forward and reverse
primers, and 1/10-diluted cDNA, according to the manufacturer’s guidelines
(Applied Biosystems). To normalize for experimental variation in cDNA synthesis and RNA input, PCRs for ubiquitin-conjugating enzyme (UBC) E2D 2
were conducted in parallel. The primer pairs used are listed in Table S2.
Western blotting. Equal amounts of total cellular protein from FACSpurified populations of thymocytes (CD4+CD8+, CD8+CD4, CD4+CD25,
and CD4+CD25+) and splenic T cells (CD4+CD25 and CD4+CD25+)
were loaded on 10% Novex gels (Invitrogen) and then subjected to
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MATERIALS AND METHODS

rela/ hemopoietic cell chimeras. Control (rela+/+ or rela+/) and rela/
thymocytes and T cells (all Ly5.2+) were generated by engrafting irradiated
(2 × 550 Rad) wt (Ly5.1) mice with 106 E13 fetal liver hemopoietic progenitors as previously described (Grossmann et al., 1999)
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e lectrophoresis and Western blotting, performed as previously described
(Banerjee et al., 2006) using RelA and c-Rel–specific antisera (Grumont and
Gerondakis, 1994) or anti-Foxp3 antibodies. Blots were stripped and re
probed with anti–-actin antibodies. Western blots on nuclear and cytoplasmic extracts, prepared as previously described (Grumont and Gerondakis,
1994), were conducted as described earlier in this section and probed with
antibodies to c-Rel, after which the blots were stripped and reprobed with
anti-ERK (Santa Cruz Biotechnology, Inc.) or histone H3–specific antibodies (Santa Cruz Biotechnology, Inc.).

T reg cell conversion in vivo. CD4+CD25 splenic T cells (>96% purity) isolated by flow cytometry from wt (C57BL/6, Ly5.1+, and Ly5.2+) and
c-rel/ (Ly5.2+) mice were mixed at a 1:1 ratio, and 5 × 104 cells from mixtures of either wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) and c-rel/ (Ly5.2+)
CD4+CD25 T cells were injected intravenously into rag-1/ mice. 18 d
later, cell suspensions from the spleen and mesenteric lymph nodes of individual mice were stained with anti–CD4-APC, anti–CD8-PerCP, anti–
CD45.1-PE, and either anti–CD25-FITC or anti–FoxP3-FITC. Stained
cells were analyzed using a FACSCalibur and the data analyzed using Flow
Jo software (Tree Star, Inc.).
T reg cell homeostatic proliferation. CD4+CD25+ splenic T cells (>90%
Foxp3+) purified by flow cytometry from wt (C57BL/6, Ly5.1+ and Ly5.2+)
and c-rel/ (Ly5.2+) mice were mixed in equal numbers (1:1 ratio) and
5 × 104 cells from mixtures either wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+)
and c-rel/(Ly5.2+) CD4+CD25+ T cells were injected intravenously into
rag-1/ mice. Between 4 and 8 wk later, cell suspensions from the spleens and
mesenteric lymph nodes of individual mice were stained with anti–CD4-PerCP,
anti–CD8-PE, anti–CD45.1-APC, and anti–FoxP3-FITC antibodies. Stained
cells were analyzed using a FACSCalibur and the data analyzed using Flow
Jo software.
Infecting T cells with Foxp3-expressing retroviruses. A full-length
cDNA clone encoding mouse Foxp3 (provided by S. Barry, Child Health
Research Institute, Adelaide, Australia) was inserted into the pMY-EGFP
retroviral vector (Grumont et al., 2004), and stocks of control (MY-EGFP)
or MY-EGFP/Foxp3 virus were generated by transfecting Phoenix cells.
Purified CD4+CD25 T cells activated in culture with anti-CD3 antibodies
plus IL-2 (50 U/ml) were infected with MY-EGFP or MY-EGFP/Foxp3
virus using a spin infection procedure (Grumont et al., 2004). After two
rounds of infection, 20–30% of cultured cells were GFP positive.
In vitro suppression assay. Purified wt CD4+CD25 T cells (2.5 × 104)
together with varying ratios of wt or c-rel/ splenic CD4+CD25+ T cells
were activated with 1 µg/ml anti-CD3 mAb (145-2C11) in the presence of
105 irradiated (3,000 Rad) T cell–depleted wt splenocytes in 96-well round
bottom plates for 72 h. These assays were also performed using either TGF-–
converted T reg cells or CD4+CD25+ T cells generated by infecting wt or
c-rel/ CD4+CD25 T cells with a retrovirus expression Foxp3. All cultures
were pulsed with 1 µCi of 3H-thymidine for the final 8 h of incubation and
then analyzed by scintillation counting.
12 of 14

Online supplemental material. Fig. S1 shows c-Rel expression in nuclear
and cytoplasmic fractions of resting and activated B cells. Fig. S2 shows cultured CD4+ and T reg cell numbers after TGF- (with or without IL-2
treatment). Fig. S3 shows that TCR-activated c-rel/ T cells demonstrate
diminished proliferation after TGF- treatment. Fig. S4 shows T reg cell
conversion in vivo. Fig. S5 shows Foxp3 expression in populations of purified peripheral nT reg cells and converted CD4+CD25 T cells. Fig. S6
shows T reg cell control of antigen-specific effector T cell proliferation
in c-rel/ mice. Table S1 shows the numbers of CD4+CD25+,
CD4+CD25+Foxp3+, and CD4+CD25Foxp3+ cells in the thymus and
spleen of 2-, 5-, and 28-d-old wt and c-rel/ mice. Table S2 shows sequences of the primers used for determining quantitative real-time PCR
analysis of gene expression in wt and c-rel/ CD4+CD25 and CD4+CD25+
thymocytes and splenic T cells. Online supplemental material is available at
http://www.jem.org/cgi/content/full/jem.20091411/DC1.
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SUPPLEMENTAL MATERIAL

Figure S1. c-Rel expression in nuclear and cytoplasmic fractions of resting and activated B cells. Cytoplasmic and nuclear fractions from
equivalent numbers (3 × 106) of purified resting or anti-IgM (25 µg/ml)–activated (60 min) B cell cultures were subjected to Western blot analysis and
probed with c-Rel–specific antibodies as described in Materials and methods. c-Rel levels in whole cell extracts (2 × 106) of untreated and activated B
cells from these culture is also shown. The data are representative of two independent experiments.

Figure S2. Cultured CD4+ and T reg cell numbers after TGF- (with or without IL-2) treatment. 4 d after stimulating wt or c-rel/ CD4+CD25
T cells with anti-CD3 antibodies and irradiated T cell–depleted APC in the absence or presence of TGF- (with or without IL-2) total numbers of CD4+ T
cells and T reg cells (Foxp3+) were quantified by flow cytometry. The data represents the standard error of the mean for four independent experiments. In
each independent experiment, there were three replicate cultures of wt and c-rel/ cells for every type of stimulation.

Figure S3. TCR-activated c-rel/ T cells demonstrate diminished proliferation after TGF- treatment. wt or c-rel/ CD4+CD25 T cells were
stimulated for 4 d in culture with anti-CD3 antibodies and irradiated T cell–depleted APC in the absence or presence of TGF- (with or without IL-2). Cultures were pulsed with 1 µCi 3H-thymidine for the final 8 h of culture, after which cells were harvested and incorporated radioactive thymidine was determined. The data represents the standard error of the mean for four independent experiments. In each independent experiment, there were three
replicate cultures of wt and c-rel/ cells for every type of stimulation.
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Figure S5. Foxp3 expression in populations of purified peripheral nT reg cells and converted CD4+CD25 T cells. (A) Purified wt and c-rel/
populations of splenic CD4+CD25+ T cells were stained for Foxp3 expression. Representative purity of the sorted populations and the levels of Foxp3 expression are shown. The data are representative of six independent experiments. (B) Typical purity in GFP+ populations of wt and c-rel/ CD4+CD25 T
cells transduced with Foxp3/GFP retrovirus. Western blotting demonstrates Foxp3 expression in these populations. The data are representative of four
independent experiments. (C) Purity of FACS-purified wt and c-rel/ CD4+CD25+ T cells generated in culture by TGF- plus IL-2 stimulation. Foxp3 expression in these populations is also shown. The data are representative of four independent experiments.
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Figure S4. T reg cell conversion in vivo. Mesenteric lymph node cells isolated from rag-1/ mice injected 18 d earlier with either a 1:1 mix of purified splenic CD4+CD25 wt (Ly5.1+ and Ly5.2+) or wt (Ly5.1+) and c-rel/ (Ly5.2+) T cells were stained with antibodies specific for CD4, CD8, CD45.1
(Ly5.1) and Foxp3. The data compares the percentages of wt (Ly5.1+ and Ly5.2+, squares and circles, respectively) and c-rel/ (Ly5.2+, triangles)
CD4+Foxp3+ cells detected in the mesenteric lymph nodes of individual mice receiving each mixture of cells. The data were analyzed using a paired T test
and is representative of two independent experiments, with a minimum of five mice in each recipient group. Horizontal bars represent the mean values of
the data. Error bars represent SD.
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Figure S6. T reg cell control of antigen-specific effector T cell proliferation in c-rel/ mice. (A) Anti-CD25 antibody depletion of T reg cells
augments the antigen-induced proliferation of CD8+ OT-I transgenic T cells. 2 × 106 purified CD8+ splenic and lymph node T cells (V2+) from CD45.1+
OT-I mice were injected into wt mice that were either untreated (six mice) or pretreated with four 1-mg doses of anti-CD25 mAb per mouse (five mice)
delivered over a 9-d period. At the time of cell transfer, each mouse was immunized with a combination of OVA/QuilA (100 µg OVA and 20 µg QuilA;
Steptoe et al. 2007. J. Immunol. 178:2094–2103). 7 d later, the number of CD45.1+V2+ CD8+ T cells, plus the frequency of CD25+Foxp3+ T cells (as a percentage of CD4+ cells) in the draining inguinal lymph nodes of mice were determined using a flow cytometry bead assay (Steptoe et al. 2007. J. Immunol.
178:2094–2103). The data are representative of two independent experiments. (B) Residual T reg cell numbers in c-rel/ mice limit the OVA-dependent
expansion of OT-I CD8+ T cells. wt and c-rel/ mice (both CD45.2+) injected with equal numbers (2 × 106) of V2+OT-I CD8+ T cells purified from the
spleen and lymph node were immunized with OVA/QuilA and then, 7 d later, inguinal lymph node CD45.1+V2+CD8+ and CD4+CD25+Foxp3+ T cells were
quantified as described in A. The data obtained from individual mice in this experiment is representative of two independent experiments. In both experiments, six wt and six c-rel/ mice were used in each experimental group. Horizontal bars represent the mean values of the data.
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Table S1. Numbers of CD4+CD25+, CD4+CD25+Foxp3+, and CD4+CD25Foxp3+ cells in the thymus and spleen of 2-, 5-, and 28d-old wt and c-rel/ mice
Cell type and day

Thymus

Spleen

WT

c-Rel/

Mean

SEM

Mean

SEM

Mean

SEM

Mean

SEM

23,010
22,860
259,702

2,378
5,699
47,956

24,411
6,672
106,630

3,620
1,798
7,523

341
22,829
650,397

42
3,813
53,711

181
4,965
211,402

34
1,820
12,770

576
3,260
102,234

159
595
14,509

29
291
29,542

12
53
1,264

45
16,142
694,062

9
3,099
43,890

0
1,180
176,034

0
602
11,065

934
3,599
96,504

231
651
10,221

81
825
30,710

15
159
4,633

132
4,893
346,423

33
658
22,407

8
784
36,023

4
310
3,701

CD25+

Mean refers to the mean numbers of CD4+CD25+, CD4+CD25+Foxp3+, and CD4+CD25Foxp3+ thymocytes and splenic T cells (± SEM) in 2-, 5-, and 28-d-old wt and c-rel/
mice. The data were compiled in two independent experiments from a total of n = 10–20 for D2 and D5 samples and n = 5 for D28 samples.
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CD4SP
D2
D5
D28
CD4SP CD25+Foxp3+
D2
D5
D28
CD4SP CD25Foxp3+
D2
D5
D28

WT

c-Rel/
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Table S2. Sequences of the primers used for determining quantitative real-time PCR analysis of gene expression in wt and crel/ CD4+CD25 and CD4+CD25+ thymocytes and splenic T cells
Name

JEM

5-AAGAGAATCCACAAGGAATTGAATG-3
5-CAACAGGACCTGCTGAACACTG-3
5-GGCCCTTCTCCAGGACAG-3
5-GCTGATCATGGCTGGGTTGT-3
5-AGGTCAGACAGAGCCATTTTGAGT-3
5-CCGTGTCCCCACAAAAGATATATTT-3
5-CCTGAGCAGGATGGAGAATTACA-3
5-TCCAGAACATGCCGCAGAG-3
5-CCACTGAGCAATACGGCCATT-3
5-CAGCTGCCATATGTGCAGGC-3
5-GGGCTCAGTTGCATAAACCGA-3
5-ACACTGCCAGCTTTTGGTTTCC-3
5-CCTTGCTTTTTCCAGCCACG-3
5-GGCATGGCTACCACACATGC-3
5-TGCCAAGCCTTATCGGAAATG-3
5-CCCAGGGAATTCAAATGCTCC-3
5-GCAAGGAATGTGAGGAGCTGG-3
5-CGCATGCAGTCAGGACGTGT-3
5-ACCCCCACTGATACGCCTGA-3
5-GCGCTGAATCGAAAGCCCT-3
5-TTGTACCTGCTCCGGAAGGC-3
5-TGTGCGTCTGTGTGTTCCTCC-3
5-TGTCCACAGGAAGAAGAAGGAGG-3
5-CTCGGTTTCGGCCC ACAC-3
5-AATCGGGAGCCTTCGAGTCA-3
5-CTGTGGGTATTTGCCGCCTT-3
5-TTTCCTTGGGGTCACTCAAC-3
5-AGGCCATGAGAGTTGTGAGC-3
5-CCAAGACAGTCCTGTGACCA-3
5-AACCAACATGTTCCCTGTCC-3
5-TCATAAGAGTCAGGTGGTCTTGG-3
5-GAGGTAGCTGTGCCACCTTT-3
5-GGCCTGTCCTGAGTCTGAAT-3
5-CACAGGGTTGGAAATTGAGG-3
5-CTGGCCAGGAAAACAAACAT-3
5-CAAGCGCTTCTGTTGTGAAG-3
5-TACACAGTGCAAACCGCTCG-3
5-GCAGGTACTCAGATTTCTAGCCAGG-3
5-TCTTTGAGCCTTGGTTGGTC-3
5-TCACTAGTGGCCTGCTGTCA
5-AGGACAACAGCAGGGCTCTA
5-CCTCTAACCTCTTCCCCTGG
5-GGCTTCACAATCTTCAAGGTGG
5-CGCATGGGAGCAGAGGG
5-GCTTTCTGCCACACATTTAGACTCTTTGAAAA
5-CATATTTTCAAAGAGTCTAAATGTGTGGCAGA
5-AGCAGCAGGTGAACGTCCTG
5-CACCTTGCTCACTTTGCGGT
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mUBC forward
mUBC reverse
mFoxp3 forward
mFoxp3 reverse
mCD25 forward
mCD25 reverse
mIL-2 forward
mIL-2 reverse
mGITR forward
mGITR reverse
mCtla4 forward
mCtla4 reverse
mIL-7 forward
mIL-7 reverse
mIL-10 forward
mIL-10 reverse
mIL-15 forward
mIL-15 reverse
mTGFb forward
mTGFb reverse
mOX40 forward
mOX40 reverse
m41BB forward
m41BB reverse
mCD40L forward
mCD40L reverse
mCD39 forward
mCD39 reverse
mCD73 forward
mCD73 reverse
mIL-12p35 forward
mIL-12p35 reverse
mEbi3 forward
mEbi3 reverse
mICOS forward
mICOS reverse
mCD127 forward
mCD127 reverse
mMAP3K8 forward
mMAP3K8 reverse
mCREM forward
mCREM reverse
mIrf4 forward
mIrf4 reverse
mZEB1 forward
mZEB1 reverse
mId1 forward
mId1 reverse

Primer sequence
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Table S2. Sequences of the primers used for determining quantitative real-time PCR analysis of gene expression in wt and crel/ CD4+CD25 and CD4+CD25+ thymocytes and splenic T cells (Continued)
Name
mBcl2l1 forward
mBcl2l1 reverse
mBcl2 forward
mBcl2 reverse
mcRel forward
mcRel reverse
mRelA forward
mRelA reverse
mNF-kB1 forward
mNF-kB1 reverse

Primer sequence
5-CCCAGAGACTGACAGCCTGA
5-TGTAGGGTGAGGGGAGAGGA
5-TCTCGTCGCTACCGTCGTGA
5-AAGAGTTCCTCCACCACCGTG
5-TTACCAGAAATGCCCAGGTC
5-AGGCCCTTCTAGGAATGGAA
5-TTCCCAATGGTCTCTCAGGA
5-GTCGCTGTCAGCACCTTAGGA
5-TCTAGCAATCATGGCGCTCG
5-CAACACAAAGCAAATGTGATCCAG
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